Suppression of lymphangiogenesis induced by Flt-4 antibody in gastric low-grade mucosa-associated lymphoid tissue lymphoma by Helicobacter heilmannii infection

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue SUPPL. 1, 2010, Pages

  Nakamura, Masahiko ^a   Matsui, Hidenori ^b   Takahashi, Tetsufumi ^a   Ogawa, Satoshi ^a   Tamura, Ryo ^a   Murayama, Somay Y ^b   Takahashi, Shinichi ^c   Tsuchimoto, Kanji ^a  

^a School of Pharmaceutical Sciences   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c KYORIN UNIVERSITY   (Japan)

Author keywords

Gastric mucosa associated lymphoid tissue lymphoma; Helicobacter heilmannii; Lymphangiogenesis; Prox 1; Vascular endothelial growth factor C

Indexed keywords

FLK 1 ANTIBODY; FLT 1 ANTIBODY; FLT 4 ANTIBODY; PROTEIN ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN C; ANTIBODY; ANTINEOPLASTIC AGENT; FLT1 PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; PROSPERO-RELATED HOMEOBOX 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN; VASCULAR ENDOTHELIAL GROWTH FACTOR C, MOUSE; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; FEMALE; HELICOBACTER HEILMANNII; HELICOBACTER INFECTION; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; MOUSE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DRUG EFFECTS; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOMA, B-CELL, MARGINAL ZONE; METABOLISM; MICROBIOLOGY; NEOVASCULARIZATION, PATHOLOGIC; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; STOMACH MUCOSA; TUMOR VOLUME; VASCULARIZATION;

ANIMALS; ANTIBODIES; ANTINEOPLASTIC AGENTS; FEMALE; GASTRIC MUCOSA; HELICOBACTER HEILMANNII; HELICOBACTER INFECTIONS; HOMEODOMAIN PROTEINS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; LYMPHANGIOGENESIS; LYMPHOMA, B-CELL, MARGINAL ZONE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; TUMOR BURDEN; TUMOR SUPPRESSOR PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 77951528010     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06230.x     Document Type: Conference Paper

References (15)

1. Morgner A, Lehn N, Andersen LP et al. Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection. Gastroenterology 2000 118 : 821 828. (Pubitemid 30243744)
2. Nakamura M, Murayama SY, Serizawa H et al. Candidatus Helicobacter heilmannii from Cynomolgus monkey brought about gastric low grade MALT lymphoma in C57BL/6 mice. Infect. Immun. 2007 75 : 1214 1222. (Pubitemid 47024733)
3. Matsui H, Aikawa C, Sekiya Y et al. Evaluation of antibiotic therapy for eradication of "Candidatus Helicobacter heilmannii". Antimicrob. Agent Chemother. 2008 52 : 2988 2989.
4. Nakamura M, Matsui H, Murayama SY et al. Interaction of VEGF to gastric low grade MALT lymphoma by Helicobacter heilmannii infection in C57BL/6 mice. Inflammopharmacology 2007 15 : 115 118. (Pubitemid 47024733)
5. Nishikawa K, Nakamura M, Takahashi S et al. Increased apoptosis and angiogenesis in gastric low-grade mucosa-associated lymphoid tissue-type lymphoma by Helicobacter heilmannii infection in C57/BL6 mice. FEMS Immunol. Med. Microbiol. 2007 50 : 268 272. (Pubitemid 46918651)
6. Nakamura M, Takahashi S, Matsui H et al. Microcirculatory alteration in low-grade mucosa-associated lymphoma by Helicobacter heilmannii infection: its relation to vascular endothelial growth factor and cyclooxygenase-2. J. Gastroenterol. Hepatol. 2008 23 (Suppl. 2 S157 60.
7. Itoh T, Yanagawa Y, Singaki M, Masubuchi N, Takahashi S, Saito S. Isolation of Helicobacter heilmannii like organism from the stomachs of cynomolgus monkeys and colonization of them in mice. Gastroenterology 1994 106 : A99.
8. Stefanini M, De Martino C, Zamboni L. Fixation of ejaculated spermatozoa for electron microscopy. Nature 1967 216 : 173 174.
9. Kato S. Enzyme-histochemical demonstration of interalobular lymphatic vessels in the mouse thymus. Arch. Histol. Cytol. 1990 53 (Suppl 87 94. (Pubitemid 20387686)
10. Sugito M, Araki K, Ogata T. Three-dimensional organization of lymphatics in the dog stomach a scanning electron microscopic study of corrosion casts. Arch. Histol. Cytol. 1996 59 : 61 70. (Pubitemid 26117365)
11. Tammela T, Zarkada G, Wallgard E et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 2008 454 : 656 660.
12. Tammela T, Enholm B, Alitalo K et al. The biology of vascular endothelial growth factors. Cardiovasc. Res. 2005 65 : 550 563. (Pubitemid 40138976)
13. Yu L, Wu X, Cheng Z et al. Interaction between bevacizumab and murine VEGF-A: a reassessment. Invest. Ophthalmol. Vis. Sci. 2008 49 : 522 527.
14. Rudge JS, Holash J, Hylton D et al. Inaugural Article: VEGF trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockade. Proc. Natl Acad. Sci. U. S. A. 2007 104 : 18363 18370. (Pubitemid 350210713)
15. Takahashi M, Yoshimoto T, Shimoda M et al. Loss of function of the candidate tumor suppressor prox1 by RNA mutation in human cancer cell. Neoplasia 2006 8 : 1003 1010. (Pubitemid 44936149)